Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association of Iodixanol (Visipaque) to Renal Function and Cardiac and Cerebrovascular Events in STEMI Patients Undergoing Primary PCI: A Prospective, Multi-National, Multi-Center, Open-Label, Observational Study

NCT03671603 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT03671603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03671603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association of Iodixanol (Visipaque) to Renal Function and Cardiac and Cerebrovascular Events in STEMI Patients Undergoing Primary PCI: A Prospective, Multi-National, Multi-Center, Open-Label, Observational Study
Lead sponsor
GE Healthcare
Phase
Observational
Overall status
Completed
Start date
November 5, 2018
Completion date
June 7, 2021
Enrollment
2,755 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, st-segment elevation myocardial infarction